These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37389184)

  • 21. Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer.
    Han P; Liu Q; Xiang J
    Oncol Lett; 2020 Jan; 19(1):707-716. PubMed ID: 31897186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation to identify tumor microenvironment-related genes of prognostic value in lung squamous cell carcinoma based on The Cancer Genome Atlas.
    Liu H; Liu B; Zhang L; Li M; Chen C; He S; Luo T; He X; Tan L
    Transl Cancer Res; 2021 Apr; 10(4):1885-1899. PubMed ID: 35116510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma.
    Du C; Cai J; Tang J; Chen Y; Díaz-Peña R; Tomita Y; Jassem J; Zhao J; Zheng D; Tu Z
    J Thorac Dis; 2024 Jan; 16(1):553-563. PubMed ID: 38410586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prognostic 11-DNA methylation signature for lung squamous cell carcinoma.
    Zhang J; Luo L; Dong J; Liu M; Zhai D; Huang D; Ling L; Jia X; Luo K; Zheng G
    J Thorac Dis; 2020 May; 12(5):2569-2582. PubMed ID: 32642165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer.
    Jiang JH; Gao J; Chen CY; Ao YQ; Li J; Lu Y; Fang W; Wang HK; de Castro DG; Santarpia M; Hashimoto M; Yuan YF; Ding JY
    Transl Lung Cancer Res; 2022 Feb; 11(2):224-237. PubMed ID: 35280307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
    Zhang R; Deng Y; Zhang Y; Zhai GQ; He RQ; Hu XH; Wei DM; Feng ZB; Chen G
    Int J Clin Exp Pathol; 2017; 10(10):10650-10665. PubMed ID: 31966409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
    Yang S; Sui J; Liang G
    PeerJ; 2017; 5():e4101. PubMed ID: 29204322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of
    Zhang X; Nie X; Long J; Yu J; Zhang P; Liu Y; Wu X; Bai Y; Mao J; Liu X; Yuan Y; Zhao H; Li L
    Ann Transl Med; 2020 Jul; 8(13):819. PubMed ID: 32793664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel CpG methylation signature to predict prognosis in lung squamous cell carcinoma.
    Lee N; Xia X; Meng H; Zhu W; Wang X; Zhang T; Zhang C; Zhang J; Luo P
    Cancer Biomark; 2021; 30(1):63-73. PubMed ID: 32924987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K; Wu Y
    BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.
    Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
    Front Immunol; 2021; 12():665407. PubMed ID: 34177903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological implications of lncRNAs, immunotherapy and DNA methylation in lung squamous cell carcinoma: a narrative review.
    Sasa GBK; Xuan C; Chen M; Jiang Z; Ding X
    Transl Cancer Res; 2021 Dec; 10(12):5406-5429. PubMed ID: 35116387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma.
    Li X; He J
    Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
    Wang X; Meng Y; Liu C; Yang H; Zhou S
    J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation Signature Genes Identification of the Lung Squamous Cell Carcinoma Occurrence and Recognition Research.
    Wang X; Shang W; Chang Y; Li X
    J Comput Biol; 2018 Oct; 25(10):1161-1169. PubMed ID: 30059254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bioinformatics analysis of RIOX2 gene in lung adenocarcinoma and squamous cell carcinoma.
    Sun B; Zhao H
    PLoS One; 2021; 16(12):e0259447. PubMed ID: 34855761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
    Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
    Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Chen R; Hong Q; Jiang J; Chen X; Jiang Z; Wang J; Liu S; Duan S; Shi S
    Oncol Lett; 2017 Oct; 14(4):4989-4994. PubMed ID: 29085512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.